The global cancer vaccines market, which achieved a market size of US$ 6.1 billion in 2022, is poised for substantial growth. The report anticipates the market to reach US$ 12.1 billion by 2028, exhibiting a robust Compound Annual Growth Rate (CAGR) of 11.61% during the forecast period from 2023 to 2028.
Cancer Vaccines: A Vital Tool in the Fight Against Cancer
Cancer, characterized by the uncontrolled growth of abnormal cells in the body, is a formidable health challenge. Various medications and vaccines have been developed for cancer treatment, with vaccines categorized into preventive and therapeutic types.
Preventive cancer vaccines target oncovirus-induced cancers and protect against human papillomavirus (HPV), while therapeutic vaccines stimulate the body's adaptive immune system using tumor antigens. The market offers different vaccine types, including antigen, dendritic cell, and anti-idiotype vaccines.
Market Trends and Growth Drivers
Several key trends and growth drivers are shaping the cancer vaccines market:
Rising Cancer Prevalence: The increasing incidence of cancer, largely driven by factors such as tobacco consumption and changing lifestyles, is a primary driver of market growth.
Government Initiatives: Government initiatives in several countries to introduce innovative cancer vaccines and significant funding for viral recombinant cancer vaccine research are encouraging market adoption.
FDA-Approved Vaccines: FDA-approved vaccines, including HPV and hepatitis B vaccines, are effectively reducing the risk of certain cancers, such as liver cancer, driving market expansion.
Technological Advancements: Continuous advancements in cancer treatment technologies are focusing on developing effective and specific cancer treatments.
Healthcare Infrastructure: Improvements in healthcare infrastructure, a growing geriatric population vulnerable to various chronic diseases like cancer, and increased consumer awareness of symptoms and available treatments are contributing to market growth.
Key Market Segments
The report offers comprehensive insights into key market segments:
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Dendritic Cells Cancer Vaccines
Recombinant Cancer Vaccines
Antigen/Adjuvant Cancer Vaccines
Viral Vector and DNA Cancer Vaccines
Whole-cell Cancer Vaccines
Middle East and Africa
Key players in the cancer vaccines market include Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc., and Vaccitech plc, among others.
Key Questions Addressed
The report answers critical questions regarding the global cancer vaccines market:
Market Size: What is the current size of the global cancer vaccines market?
Growth Rate: What is the projected growth rate during 2023-2028?
Key Drivers: What factors are driving the global cancer vaccines market?
Impact of COVID-19: How has the COVID-19 pandemic affected the market?
Market Segmentation: What is the market segmentation based on type, technology, indication, and end user?
Regional Insights: Which regions are pivotal in the global cancer vaccines market?
Key Players: Who are the key players and companies operating in the market?
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Allied Market Research published a report, titled, "LED Panel Light Market By Type, Sales Channel, Voltage, and Application: Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global LED panel...
The shrink sleeve and stretch sleeve labels market size is expected to grow by USD 4.1 billion between 2022 and 2027. However, the growth momentum of the market will progress at a CAGR of 5.1% during the forecast period. The market is segmented by...
CE Brands Inc. ("CE Brands", "we", "our", or the "Company"), a data-driven consumer-electronics company, today announced its financial results for the six-months ("Q2 2024") ended September 30, 2023. The related financial statements and...
Forward Water Technologies Corp. (the "Company") is pleased to announce that it has filed its condensed consolidated audited financial statements and related management's discussion and analysis for the three and six months ended September...
The "Philippines Glyphosate Market Outlook: Market Forecast By Application and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.
Philippines Glyphosate Market size is anticipated to grow at a CAGR of 3.9% during...